The use of ADSCs as a treatment for chronic stroke

Cell Transplantation

Volumn 23, Issue 4-5, 2014, Pages 541-547

  Chan, Tzu Min ^a,b   Harn, Horng Jyh ^a,c   Lin, Hui Ping ^d   Chiu, Shao Chih ^a,c   Lin, Po Cheng ^e   Wang, Hsin I ^e   Ho, Li Ing ^f   Chuu, Chih Pin ^d   Chiou, Tzyy Wen ^g   Hsieh, An Cheng ^a   Chen, Yu Wen ^a   Ho, Wen Yu ^h,i   Lin, Shinn Zong ^a,c,h  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Everfront Biotech Inc   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e Gwo Xi Stem Cell Applied Technology   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g NATIONAL DONG HWA UNIVERSITY   (Taiwan)

^h CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

ⁱ JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Adipose tissue derived stem cells (ADSCs); Angiogenesis; Cerebrovascular; Chronic stroke; Gliosis; Hemorrhagic; Ischemic; Neurotrophic factors

Indexed keywords

FREE RADICAL; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 10; INTERLEUKIN 18; NESTIN; NEUROTROPHIC FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; NERVE GROWTH FACTOR;

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; APOPTOSIS; ASTROCYTE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOTRANSPLANTATION; BLOOD CLOT LYSIS; BLOOD VESSEL RUPTURE; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; CARTILAGE CELL; CELL SURVIVAL; CELL THERAPY; CEREBROVASCULAR ACCIDENT; CHROMOSOME DELETION; CHRONIC DISEASE; CHRONIC STROKE; DERMATOMYOSITIS; DISEASE CLASSIFICATION; FOLLOW UP; GLIOSIS; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOREACTIVITY; IN VITRO STUDY; INCIDENCE; INFLAMMATION; INTRACEREBROVENTRICULAR TRANSPLANTATION; INTRAVENOUS ADMINISTRATION; KARYOTYPING; LIVER CELL; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTIPLE SCLEROSIS; MUSCLE CELL; NERVE CELL DIFFERENTIATION; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUTRIENT SUPPLY; OLIGODENDROGLIA; OSTEOBLAST; POLYMYOSITIS; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL TRANSPLANTATION; SUBVENTRICULAR ZONE; THERAPY EFFECT; THROMBOEMBOLISM; VASCULAR FRAGILITY; VASCULARIZATION; ADIPOSE TISSUE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOMODULATION; METABOLISM; STEM CELL; STROKE;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CHRONIC DISEASE; HUMANS; IMMUNOMODULATION; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTORS; STEM CELL TRANSPLANTATION; STEM CELLS; STROKE;

EID: 84900412710     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368914X678409     Document Type: Review

References (79)

1. Altes, A.; Abellan, M. T.; Mateo, J.; Avila, A.; Marti-Vilalta, J. L.; Fontcuberta, J. Hemostatic disturbances in acute ischemic stroke: A study of 86 patients. Acta Haematol. 94(1):10-15; 1995.
2. Baer, P. C.; Geiger, H. Adipose-derived mesenchymal stromal/stem cells: Tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012:812693; 2012.
3. Beck, H.; Semisch, M.; Culmsee, C.; Plesnila, N.; Hatzopoulos, A. K. Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke. Am. J. Pathol. 173(1):77-92; 2008.
4. Bjorklund, A. Cell replacement strategies for neurodegenerative disorders. Novartis Found. Symp. 231:7-15; discussion 16-20; 2000.
5. Caplan, A. I.; Dennis, J. E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98(5):1076-1084; 2006.
6. Chang, Y. C.; Shyu, W. C.; Lin, S. Z.; Li, H. Regenerative therapy for stroke. Cell Transplant. 16(2):171-181; 2007.
7. Chen, A. Z.; Liu, N.; Huang, H.; Lin, F. F.; Liu, D. S.; Lin, X. H. [Outgrowth of neuronal axons on adipose-derived stem cell transplanting for treatment of cerebral infarction in rats]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27(8):868-871; 2011.
8. Chen, J.; Tang, Y. X.; Liu, Y. M.; Hu, X. Q.; Liu, N.; Wang, S. X.; Zhang, Y.; Zeng, W. G.; Ni, H. J.; Zhao, B.; Chen, Y. F.; Tang, Z. P. Transplantation of adipose-derived stem cells is associated with neural differentiation and functional improvement in a rat model of intracerebral hemorrhage. CNS Neurosci. Ther. 18(10):847-854; 2012.
9. Cho, Y. J.; Song, H. S.; Bhang, S.; Lee, S.; Kang, B. G.; Lee, J. C.; An, J.; Cha, C. I.; Nam, D. H.; Kim, B. S.; Joo, K. M. Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J. Neurosci. Res. 90(9):1794-1802; 2012.
10. Chung, J. Y.; Kim, W.; Im, W.; Yoo, D. Y.; Choi, J. H.; Hwang, I. K.; Won, M. H.; Chang, I. B.; Cho, B. M.; Hwang, H. S.; Moon, S. M. Neuroprotective effects of adipose-derived stem cells against ischemic neuronal damage in the rabbit spinal cord. J. Neurol. Sci. 317(1-2):40-46; 2012.
11. Chung, M. T.; Zimmermann, A. S.; Paik, K. J.; Morrison, S. D.; Hyun, J. S.; Lo, D. D.; McArdle, A.; Montoro, D. T.; Walmsley, G.; Senarath-Yapa, K.; Sorkin, M.; Rennert, R.; Chen, H. H.; Chung, A. S.; Vistnes, D.; Gurtner, G. C.; Longaker, M. T.; Wan, D. C. Isolation of human adiposederived stromal cells using laser-assisted liposuction and their therapeutic potential in regenerative medicine. Stem Cells Transl. Med. 2(10):797-807; 2013.
12. Diener, H. C.; Foerch, C.; Riess, H.; Rother, J.; Schroth, G.; Weber, R. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment. Lancet Neurol. 12(7):677-688; 2013.
13. Ding, D. C.; Lin, C. H.; Shyu, W. C.; Lin, S. Z. Neural stem cells and stroke. Cell Transplant. 22(4):619-630; 2013.
14. Ding, D. C.; Shyu, W. C.; Lin, S. Z. Mesenchymal stem cells. Cell Transplant. 20(1):5-14; 2011.
15. Donizetti-Oliveira, C.; Semedo, P.; Burgos-Silva, M.; Cenedeze, M. A.; Malheiros, D. M.; Reis, M. A.; Pacheco-Silva, A.; Camara, N. O. Adipose tissue-derived stem cell treatment prevents renal disease progression. Cell Transplant. 21(8):1727-1741; 2012.
16. Du, H. W.; Liu, N.; Wang, J. H.; Zhang, Y. X.; Chen, R. H.; Xiao, Y. C. [The effects of adipose-derived stem cell transplantation on the expression of IL-10 and TNF-alpha after cerebral ischaemia in rats]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 25(11):998-1001; 2009.
17. Egashira, Y.; Sugitani, S.; Suzuki, Y.; Mishiro, K.; Tsuruma, K.; Shimazawa, M.; Yoshimura, S.; Iwama, T.; Hara, H. The conditioned medium of murine and human adiposederived stem cells exerts neuroprotective effects against experimental stroke model. Brain Res. 1461:87-95; 2012.
18. Fang, Z.; Yang, Q.; Xiong, W.; Li, G.; Xiao, J.; Guo, F.; Li, F.; Chen, A. Neurogenic differentiation of murine adipose derived stem cells transfected with EGFP in vitro. J. Huazhong Univ. Sci. Technol. Med. Sci. 30(1):75-80; 2010.
19. Flor-de-Lima, F.; Lisboa, L.; Sarmento, A.; Almeida, J.; Mota, T. Mycotic brain aneurysm and cerebral hemorrhagic stroke: A pediatric case report. Eur. J. Pediatr. 172(9):1285-1286; 2013.
20. Galvez, B. G.; San Martin, N.; Rodriguez, C. TNF-alpha is required for the attraction of mesenchymal precursors to white adipose tissue in Ob/ob mice. PLoS One 4(2):e4444; 2009.
21. Gimble, J. M.; Bunnell, B. A.; Frazier, T.; Rowan, B.; Shah, F.; Thomas-Porch, C.; Wu, X. Adipose-derived stromal/ stem cells: A primer. Organogenesis 9(1):3-10; 2013.
22. Ginsberg, M. D. Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology 55(3):363-389; 2008.
23. Graber, J. J.; Nayak, L.; Deangelis, L. M. Use of recombinant tissue plasminogen activator in cancer patients with acute stroke. J. Neurooncol. 107(3):571-573; 2012.
24. Gutierrez-Fernandez, M.; Rodriguez-Frutos, B.; Otero-Ortega, L.; Ramos-Cejudo, J.; Fuentes, B.; Diez-Tejedor, E. Adipose tissue-derived stem cells in stroke treatment: From bench to bedside. Discov. Med. 16(86):37-43; 2013.
25. Gutierrez-Fernandez, M.; Rodriguez-Frutos, B.; Ramos-Cejudo, J.; Otero-Ortega, L.; Fuentes, B.; Diez-Tejedor, E. Stem cells for brain repair and recovery after stroke. Expert Opin. Biol. Ther. 13(11): 1479-1483; 2013.
26. Gutierrez-Fernandez, M.; Rodriguez-Frutos, B.; Ramos-Cejudo, J.; Teresa Vallejo-Cremades, M.; Fuentes, B.; Cerdan, S.; Diez-Tejedor, E. Effects of intravenous administration of allogenic bone marrow-and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res. Ther. 4(1):11; 2013.
27. Hinkle, J. L.; Guanci, M. M. Acute ischemic stroke review. J. Neurosci. Nurs. 39(5):285-293; 2007.
28. Hocker, S.; Morales-Vidal, S.; Schneck, M. J. Management of arterial blood pressure in acute ischemic and hemorrhagic stroke. Neurol. Clin. 28(4):863-886; 2010.
29. Huang, S. J.; Fu, R. H.; Shyu, W. C.; Liu, S. P.; Jong, G. P.; Chiu, Y. W.; Wu, H. S.; Tsou, Y. A.; Cheng, C. W.; Lin, S. Z. Adipose-derived stem cells: Isolation, characterization, and differentiation potential. Cell Transplant. 22(4):701-709; 2013.
30. Ikegame, Y. Among mesenchymal stem cells: For the best therapy after ischemic stroke. Stem Cell Res. Ther. 4(1):9; 2013.
31. Ikegame, Y.; Yamashita, K.; Hayashi, S.; Mizuno, H.; Tawada, M.; You, F.; Yamada, K.; Tanaka, Y.; Egashira, Y.; Nakashima, S.; Yoshimura, S.; Iwama, T. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13(6):675-685; 2011.
32. Jagatha, B.; Divya, M. S.; Sanalkumar, R.; Indulekha, C. L.; Vidyanand, S.; Divya, T. S.; Das, A. V.; James, J. In vitro differentiation of retinal ganglion-like cells from embryonic stem cell derived neural progenitors. Biochem. Biophys. Res. Commun. 380(2):230-235; 2009.
33. Jeon, D.; Chu, K.; Lee, S. T.; Jung, K. H.; Ban, J. J.; Park, D. K.; Yoon, H. J.; Jung, S.; Yang, H.; Kim, B. S.; Choi, J. Y.; Kim, S. H.; Kim, J. M.; Won, C. H.; Kim, M.; Lee, S. K.; Roh, J. K. Neuroprotective effect of a cell-free extract derived from human adipose stem cells in experimental stroke models. Neurobiol. Dis. 54:414-420; 2013.
34. Jin, K.; Mao, X.; Xie, L.; Greenberg, R. B.; Peng, B.; Moore, A.; Greenberg, M. B.; Greenberg, D. A. Delayed transplantation of human neural precursor cells improves outcome from focal cerebral ischemia in aged rats. Aging Cell 9(6):1076-1083; 2010.
35. Jin, K.; Mao, X. O.; Sun, Y.; Xie, L.; Greenberg, D. A. Stem cell factor stimulates neurogenesis in vitro and in vivo. J. Clin. Invest. 110(3):311-319; 2002.
36. Kalantri, A.; Kalantri, S. Distinguishing hemorrhagic stroke from ischemic stroke. JAMA 304(12):1327-1328; author reply 1328; 2010.
37. Kang, S. K.; Lee, D. H.; Bae, Y. C.; Kim, H. K.; Baik, S. Y.; Jung, J. S. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp. Neurol. 183(2):355-366; 2003.
38. Kim, J. M.; Lee, S. T.; Chu, K.; Jung, K. H.; Song, E. C.; Kim, S. J.; Sinn, D. I.; Kim, J. H.; Park, D. K.; Kang, K. M.; Hyung Hong, N.; Park, H. K.; Won, C. H.; Kim, K. H.; Kim, M.; Kun Lee, S.; Roh, J. K. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res. 1183:43-50; 2007.
39. Kim, K. S.; Lee, H. J.; An, J.; Kim, Y. B.; Ra, J. C.; Lim, I.; Kim, S. U. Transplantation of human adipose tissue-derived stem cells delays clinical onset and prolongs life span in ALS mouse model. Cell Transplant.; 2013.
40. Kota, S. K.; Mahapatra, G. B.; Naveed, S.; Tripathy, P. R.; Jammula, S.; Modi, K. D. Carotid intima media thickness in type 2 diabetes mellitus with ischemic stroke. Indian J. Endocrinol. Metab. 17(4):716-722; 2013.
41. Leu, S.; Lin, Y. C.; Yuen, C. M.; Yen, C. H.; Kao, Y. H.; Sun, C. K.; Yip, H. K. Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J. Transl. Med. 8:63; 2010.
42. Lin, X. H.; Liu, N.; Xiao, Y. C.; Chen, R. H.; Du, H. W.; Wang, J. H.; Zhang, Y. X.; Liu, D. S. [Effects of adiposederived stem cells transplantation on the neuronal apoptosis and the expression of Bcl-2 and caspase-12 in the brain post focal cerebral ischemia in rats]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27(1):40-43; 2011.
43. Lippi, G.; Plebani, M. Biomarker research and leading causes of death worldwide: A rather feeble relationship. Clin. Chem. Lab. Med. 51(9):1691-1693; 2013.
44. Liu, L.; Zhang, R.; Liu, K.; Zhou, H.; Tang, Y.; Su, J.; Yu, X.; Yang, X.; Tang, M.; Dong, Q. Tissue kallikrein alleviates glutamate-induced neurotoxicity by activating ERK1. J. Neurosci. Res. 87(16):3576-3590; 2009.
45. Martin, H. G.; Wang, Y. T. Blocking the deadly effects of the NMDA receptor in stroke. Cell 140(2):174-176; 2010.
46. Mattiasson, G.; Shamloo, M.; Gido, G.; Mathi, K.; Tomasevic, G.; Yi, S.; Warden, C. H.; Castilho, R. F.; Melcher, T.; Gonzalez-Zulueta, M.; Nikolich, K.; Wieloch, T. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat. Med. 9(8):1062-1068; 2003.
47. McColl, B. W.; Rothwell, N. J.; Allan, S. M. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 28(38):9451-9462; 2008.
48. Nanetti, L.; Taffi, R.; Vignini, A.; Moroni, C.; Raffaelli, F.; Bacchetti, T.; Silvestrini, M.; Provinciali, L.; Mazzanti, L. Reactive oxygen species plasmatic levels in ischemic stroke. Mol. Cell. Biochem. 303(1-2):19-25; 2007.
49. Nordlander, A.; Uhlin, M.; Ringden, O.; Kumlien, G.; Hauzenberger, D.; Mattsson, J. Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation. Transpl. Immunol. 25(2-3): 153-158; 2011.
50. Ohta, Y.; Takenaga, M.; Tokura, Y.; Hamaguchi, A.; Matsumoto, T.; Kano, K.; Mugishima, H.; Okano, H.; Igarashi, R. Mature adipocyte-derived cells, dedifferentiated fat cells (DFAT), promoted functional recovery from spinal cord injury-induced motor dysfunction in rats. Cell Transplant. 17(8):877-886; 2008.
51. Papadopoulos, S. M.; Chandler, W. F.; Salamat, M. S.; Topol, E. J.; Sackellares, J. C. Recombinant human tissuetype plasminogen activator therapy in acute thromboembolic stroke. J. Neurosurg. 67(3):394-398; 1987.
52. Park, D.; Yang, G.; Bae, D. K.; Lee, S. H.; Yang, Y. H.; Kyung, J.; Kim, D.; Choi, E. K.; Choi, K. C.; Kim, S. U.; Kang, S. K.; Ra, J. C.; Kim, Y. B. Human adipose tissue derived mesenchymal stem cells improve cognitive function and physical activity in ageing mice. J. Neurosci. Res. 91(5):660-670; 2013.
53. Ra, J. C.; Kang, S. K.; Shin, I. S.; Park, H. G.; Joo, S. A.; Kim, J. G.; Kang, B. C.; Lee, Y. S.; Nakama, K.; Piao, M.; Sohl, B.; Kurtz, A. Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J. Transl. Med. 9:181; 2011.
54. Ra, J. C.; Shin, I. S.; Kim, S. H.; Kang, S. K.; Kang, B. C.; Lee, H. Y.; Kim, Y. J.; Jo, J. Y.; Yoon, E. J.; Choi, H. J.; Kwon, E. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 20(8):1297-1308; 2011.
55. Ribo, M.; Rubiera, M.; Pagola, J.; Rodriguez-Luna, D.; Meler, P.; Flores, A.; Alvarez-Sabin, J.; Molina, C. A. Bringing forward reperfusion with oxygenated blood perfusion beyond arterial occlusion during endovascular procedures in patients with acute ischemic stroke. AJNR Am. J. Neuroradiol. 31(10):1899-1902; 2010.
56. Safford, K. M.; Hicok, K. C.; Safford, S. D.; Halvorsen, Y. D.; Wilkison, W. O.; Gimble, J. M.; Rice, H. E. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem. Biophys. Res. Commun. 294(2): 371-379; 2002.
57. Safwani, W. K.; Makpol, S.; Sathapan, S.; Chua, K. H. The impact of long-term in vitro expansion on the senescenceassociated markers of human adipose-derived stem cells. Appl. Biochem. Biotechnol. 166(8):2101-2113; 2012.
58. Safwani, W. K.; Makpol, S.; Sathapan, S.; Chua, K. H. Long-term in vitro expansion of human adipose-derived stem cells showed low risk of tumourigenicity. J. Tissue Eng. Regen. Med. 8(1):67-76; 2014.
59. Savitz, S. I.; Dinsmore, J. H.; Wechsler, L. R.; Rosenbaum, D. M.; Caplan, L. R. Cell therapy for stroke. NeuroRx 1(4):406-414; 2004.
60. Shyu, W. C.; Chen, C. P.; Lin, S. Z.; Lee, Y. J.; Li, H. Efficient tracking of non-iron-labeled mesenchymal stem cells with serial MRI in chronic stroke rats. Stroke 38(2):367-374; 2007.
61. +) implantation induces neuroplasticity by enhancing beta1 integrinmediated angiogenesis in chronic stroke rats. J. Neurosci. 26(13):3444-3453; 2006.
62. Shyu, W. C.; Lin, S. Z.; Yang, H. I.; Tzeng, Y. S.; Pang, C. Y.; Yen, P. S.; Li, H. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 110(13):1847-1854; 2004.
63. Shyu, W. C.; Lin, S. Z.; Yen, P. S.; Su, C. Y.; Chen, D. C.; Wang, H. J.; Li, H. Stromal cell-derived factor-1 alpha promotes neuroprotection, angiogenesis, and mobilization/ homing of bone marrow-derived cells in stroke rats. J. Pharmacol. Exp. Ther. 324(2):834-849; 2008.
64. Sims, N. R.; Muyderman, H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim. Biophys. Acta 1802(1):80-91; 2010.
65. Smith, E. E.; Rosand, J.; Greenberg, S. M. Imaging of hemorrhagic stroke. Magn. Reson. Imaging Clin. N. Am. 14(2):127-140; 2006.
66. Soler, R.; Fullhase, C.; Hanson, A.; Campeau, L.; Santos, C.; Andersson, K. E. Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease. J. Urol. 187(4):1491-1497; 2012.
67. Song, H. Y.; Kim, M. Y.; Kim, K. H.; Lee, I. H.; Shin, S. H.; Lee, J. S.; Kim, J. H. Synovial fluid of patients with rheumatoid arthritis induces alpha-smooth muscle actin in human adipose tissue-derived mesenchymal stem cells through a TGF-beta1-dependent mechanism. Exp. Mol. Med. 42(8):565-573; 2010.
68. Thomas, J.; Fitzpatrick, L. Acute ischemic stroke review. J. Neurosci. Nurs. 40(2):69; author reply 69; 2008.
69. Tu, W.; Xu, X.; Peng, L.; Zhong, X.; Zhang, W.; Soundarapandian, M. M.; Balel, C.; Wang, M.; Jia, N.; Lew, F.; Chan, S. L.; Chen, Y.; Lu, Y. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 140(2):222-234; 2010.
70. Wang, J. H.; Liu, N.; Du, H. W.; Weng, J. S.; Chen, R. H.; Xiao, Y. C.; Zhang, Y. X. [Effects of adipose-derived stem cell transplantation on the angiogenesis and the expression of bFGF and VEGF in the brain post focal cerebral ischemia in rats]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24(10):958-961; 2008.
71. Wardlaw, J. M.; Murray, V.; Berge, E.; del Zoppo, G.; Sandercock, P.; Lindley, R. L.; Cohen, G. Recombinant tissue plasminogen activator for acute ischaemic stroke: An updated systematic review and meta-analysis. Lancet 379(9834):2364-2372; 2012.
72. Whiteley, W. N.; Slot, K. B.; Fernandes, P.; Sandercock, P.; Wardlaw, J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: A systematic review and metaanalysis of 55 studies. Stroke 43(11):2904-2909; 2012.
73. Woo, D.; Haverbusch, M.; Sekar, P.; Kissela, B.; Khoury, J.; Schneider, A.; Kleindorfer, D.; Szaflarski, J.; Pancioli, A.; Jauch, E.; Moomaw, C.; Sauerbeck, L.; Gebel, J.; Broderick, J. Effect of untreated hypertension on hemorrhagic stroke. Stroke 35(7):1703-1708; 2004.
74. Xiong, Z. G.; Zhu, X. M.; Chu, X. P.; Minami, M.; Hey, J.; Wei, W. L.; MacDonald, J. F.; Wemmie, J. A.; Price, M. P.; Welsh, M. J.; Simon, R. P. Neuroprotection in ischemia: Blocking calcium-permeable acid-sensing ion channels. Cell 118(6):687-698; 2004.
75. Yang, A. L.; Zhou, H. J.; Lin, Y.; Luo, J. K.; Cui, H. J.; Tang, T.; Yang, Q. D. Thrombin promotes the expression of thrombospondin-1 and-2 in a rat model of intracerebral hemorrhage. J. Neurol. Sci. 323(1-2):141-146; 2012.
76. Yang, K. L.; Lee, J. T.; Pang, C. Y.; Lee, T. Y.; Chen, S. P.; Liew, H. K.; Chen, S. Y.; Chen, T. Y.; Lin, P. Y. Human adipose-derived stem cells for the treatment of intracerebral hemorrhage in rats via femoral intravenous injection. Cell. Mol. Biol. Lett. 17(3):376-392; 2012.
77. Yang, Y. C.; Liu, B. S.; Shen, C. C.; Lin, C. H.; Chiao, M. T.; Cheng, H. C. Transplantation of adipose tissue-derived stem cells for treatment of focal cerebral ischemia. Curr. Neurovasc. Res. 8(1):1-13; 2011.
78. Yuan, X.; Zhang, H.; Wei, Y. J.; Hu, S. S. Embryonic stem cell transplantation for the treatment of myocardial infarction: Immune privilege or rejection. Transpl. Immunol. 18(2):88-93; 2007.
79. Zhang, M. J.; Sun, J. J.; Qian, L.; Liu, Z.; Zhang, Z.; Cao, W.; Li, W.; Xu, Y. Human umbilical mesenchymal stem cells enhance the expression of neurotrophic factors and protect ataxic mice. Brain Res. 1402:122-131; 2011.